Envision Healthcare Co. The firm's market capitalization is $6.41 billion.
Baird downgraded Envision Healthcare (NYSE:EVHC) shares to a Hold rating in analysts report issued to investors and clients today. For example, shares of Envision Healthcare stock have traded at $134.13 per share and an analyst has set a $51.00 per share price target for the stock.
The company has a current ratio of 2.27, a quick ratio of 2.25 and a debt-to-equity ratio of 0.65. Federated Investors Inc. PA increased its position in shares of Envision Healthcare by 194.8% during the first quarter. The firm bought 36,746 shares of the company's stock, valued at approximately $1,412,000. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the company's stock. Ten analysts have made estimates for Envision Healthcare's earnings, with estimates ranging from $2.07 billion to $2.11 billion. Raymond James maintained Envision Healthcare Corporation (NYSE:EVHC) rating on Tuesday, December 12. The company had revenue of $2.08 billion during the quarter, compared to the consensus estimate of $2.02 billion.
Several brokerages recently issued reports on EVHC. Zeke Capital Advisors LLC bought a new position in shares of Envision Healthcare during the first quarter worth $229,000. They expect $0.80 earnings per share, up 1.27 % or $0.01 from last year's $0.79 per share. Nordea Investment Management AB now owns 3,341 shares of the company's stock valued at $205,000 after buying an additional 120 shares in the last quarter.
If you own shares of Envision Healthcare stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. Boston Partners grew its stake in Envision Healthcare by 362.0% in the 1st quarter. Cantor Fitzgerald maintained Envision Healthcare Corporation (NYSE:EVHC) on Tuesday, April 10 with "Hold" rating. After $0.65 actual earnings per share reported by Envision Healthcare Corporation for the previous quarter, Wall Street now forecasts 23.08 % EPS growth.
KKR said on May 29 it would buy business software company BMC Software in a deal that sources said was valued at $8.5 billion, including debt. Envision Healthcare now has a consensus rating of "Hold" and an average price target of $41.10. Royal Bank of Canada reissued a "buy" rating and issued a $72.00 price objective on shares of Envision Healthcare in a report on Wednesday, May 3rd.
Envision Healthcare Corporation (NYSE:EVHC) has declined 22.24% since June 12, 2017 and is downtrending. The deal is expected to close in the fourth quarter. The company operates through two segments, Physician Services and Ambulatory Services.
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States.